Company Deep Dive

Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.

View Deep Dive

T14.SI

HoldFallen Favourite

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited · Healthcare · China · $3.3B · Avg Vol: $406K/d

StockRank

Get insider-trade alerts

P/E (TTM)

15.1x

ROE

11.3%

D/E

0.0x

Dividend %

27.4%

COMPANY DESCRIPTION

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is a pharmaceutical company engaged in the research, development, manufacturing, and sale of traditional Chinese medicine (TCM) and chemical drugs. The company benefits from a strong brand heritage and an extensive product portfolio, particularly in established TCM formulations, granting it a recognized market position within the specialized Chinese healthcare sector. It is a historical and well-regarded player in the traditional Chinese medicine market.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	6.9B	1.2B	1.2B	1.1B	734.1M	-42.9%	704.7M	736.1M	798.9M	4.3%
EPS	1.00	0.65	0.74	1.67	1.59	12.3%	0.17	—	—	—
Shares	773.4M	200.0M	200.0M	200.0M	200.0M	-74.1%	200.0M	—	—	—
Debt	33.2M	38.5M	49.1M	4.3M	9.8M	-26.3%	14.8M	—	—	—
Equity	6.4B	973.6M	985.4M	1.2B	1.1B	-36.1%	—	—	—	—
Op CF	852.4M	101.1M	102.8M	138.0M	68.8M	-46.7%	120.2M	—	—	—
Inv CF	-311.9M	-1.8M	-84.9M	51.1M	-210.2M	—	—	—	—	—
Fin CF	-244.7M	-35.3M	-124.5M	-47.8M	-146.4M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)-8.9%

SMA 50SMA 200

$2.55

RSI (14)

51.4

52W High

$3.19

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

34.8%97.6

ROE

11.3%76.3

GP/Assets

5.6%20.9

Op. Margin

21.9%85.8

FCF/Assets

0.8%49.9

Piotroski

550.6

Int. Cover

50.0x89.4

D/E Ratio

0.02x81.0

Current Ratio

1.38x22.6

Value

P/E (TTM)

15.1x71.3

EV/EBITDA

-9.2x25.0

P/FCF

42.3x31.3

P/B

15.0x7.6

P/S

4.7x43.2

Div Yield

27.4%100.0

Momentum

52W High %

80%68.3

RS 6M

-28%34.2

SMA 50/200

1.02x63.6

EPS Rev 4W

0.0%34.5

EPS Rev 12W

+27.6%93.7

EPS Improve

+53%56.5

Q Growth

-86%3.0

FUNDAMENTALS

Market Cap

$3.3B

P/E (Forward)

9.9x

Gross Margin

73.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of T14.SI are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
T14.SI	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(you)	$3.3B	59	Hold
000623.SZ	Jilin Aodong Pharmaceutical Group Co., Ltd.	$3.3B	62	Hold
300558.SZ	Betta Pharmaceuticals Co., Ltd.	$3.2B	54	Hold
002317.SZ	Guangdong Zhongsheng Pharmaceutical Co., Ltd.	$3.3B	51	Hold
688131.SS	Shanghai Haoyuan Chemexpress Co., Ltd.	$3.0B	52	Hold
300199.SZ	Hybio Pharmaceutical Co., Ltd.	$3.1B	51	Hold
603858.SS	Shandong Buchang Pharmaceuticals Co., Ltd.	$2.4B	64	Hold
002399.SZ	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	$2.3B	65	Hold
600664.SS	Harbin Pharmaceutical Group Co., Ltd.	$3.4B	73	Buy
600085.SS	Beijing Tongrentang Co., Ltd	$5.0B	65	Buy

Peer medians: ROE 4.3% · P/E 28.0x · Gross margin 53.1%

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI): Stock Score Summary

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) has a MoatMap StockRank of 59/100 based on Quality (62/100), Value (42/100), and Momentum (49/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$2.55
Market Cap	$3.3B
P/E (TTM)	15.12
P/E (Forward)	9.88
Price/Book	15.00
Return on Equity	11.3%
Return on Invested Capital	34.8%
Debt/Equity	0.02x
Gross Margin	73.2%
Operating Margin	21.9%
Revenue Growth	-21.4%
Dividend Yield	27.4%
Free Cash Flow	$77M

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited’s (T14.SI) StockRank?: MoatMap’s StockRank for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) is 59/100, with a Hold signal. It is a composite of Quality (62), Value (42), and Momentum (49) factor ranks across MoatMap’s 20,000+ stock universe.
Does Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited have an economic moat?: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) has a Quality factor score of 62/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited a buy, hold, or sell?: MoatMap’s current signal for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) is Hold, based on a StockRank of 59/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in?: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).